Position in BMY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,209,266
-$135,705 QoQ
Shares Held
38,342
-0.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#791
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AdvisorNet Financial, Inc holds $20,577,968 across 14 Drug Manufacturers - General names. BMY ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,169 | $3,852,470 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
27,109 | $3,424,951 | |
| 3 | LLY |
ELI LILLY & Co
|
2,556 | $3,065,743 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
38,342 | $2,209,266 | |
| 5 | AZN |
Astrazeneca PLC
|
11,574 | $2,194,661 | |
| 6 | ABBV |
AbbVie Inc.
|
6,595 | $1,659,565 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,405 | $1,337,042 | |
| 8 | GSK |
GSK plc
|
17,988 | $942,930 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,209,266 | 38,342 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,344,971 | 38,664 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,126,206 | 39,418 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,661,619 | 36,843 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $1,727,265 | 37,314 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $2,152,093 | 35,286 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $1,968,683 | 34,807 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,874,126 | 36,222 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,472,321 | 35,452 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $1,810,143 | 33,379 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,500,355 | 29,241 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $1,783,046 | 30,721 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $2,803,887 | 43,845 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,916,911 | 42,085 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $3,015,064 | 41,905 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $2,993,102 | 42,103 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $3,054,821 | 39,673 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $2,370,699 | 32,462 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,966,394 | 31,538 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,883,617 | 31,834 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $4,620,736 | 69,152 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $4,273,017 | 67,686 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $4,040,882 | 65,144 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $3,894,311 | 64,593 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $3,707,575 | 63,054 | Shares | Sole | 2020-08-26 | |
| 2020-03-31 | $3,675,607 | 65,942 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||